Large-scale transcriptomic analysis of coding and non-coding pathological biomarkers, associated with the tumor immune microenvironment of thyroid cancer and potential target therapy exploration
Papillary thyroid carcinoma (PTC) is the most prevalent endocrine malignancy with a steadily increasing global incidence in recent decades. The pathogenesis of PTC is poorly understood, and the present diagnostic protocols are deficient. Thus, identifying novel prognostic biomarkers to improve our u...
Main Authors: | Ming-Lang Shih, Bashir Lawal, Sheng-Yao Cheng, Janet O. Olugbodi, Ahmad O Babalghith, Ching-Liang Ho, Simona Cavalu, Gaber El-Saber Batiha, Sarah Albogami, Saqer S. Alotaibi, Jih-Chin Lee, Alexander T. H. Wu |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2022-08-01
|
Series: | Frontiers in Cell and Developmental Biology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fcell.2022.923503/full |
Similar Items
-
Pan-Cancer Analysis of Immune Complement Signature C3/C5/C3AR1/C5AR1 in Association with Tumor Immune Evasion and Therapy Resistance
by: Bashir Lawal, et al.
Published: (2021-08-01) -
Seven Genes Associated With Lymphatic Metastasis in Thyroid Cancer That Is Linked to Tumor Immune Cell Infiltration
by: Linfeng Wu, et al.
Published: (2022-01-01) -
Identification of DPP4/CTNNB1/MET as a Theranostic Signature of Thyroid Cancer and Evaluation of the Therapeutic Potential of Sitagliptin
by: Sheng-Yao Cheng, et al.
Published: (2022-02-01) -
Identification and validation of a pyroptosis-related prognostic signature for thyroid cancer
by: Pu Wu, et al.
Published: (2021-10-01) -
MXD3 as an onco-immunological biomarker encompassing the tumor microenvironment, disease staging, prognoses, and therapeutic responses in multiple cancer types
by: Szu-Yuan Wu, et al.
Published: (2021-01-01)